Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs

12 June 2026 Announcement no. 8 Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs Pharma Equity Group A/S ("PEG" or the "Company") today announces that it has received a final and binding international arbitral award rendered by the Danish Institute of Arbitration in the proceedings against Interpatium - Promoção Imobiliária LDA, Madeira, Portugal. The Arbitral Tribunal has ruled entirely in favour of PEG and awarde